The Sonic Healthcare (ASX:SHL) share price is rising this Wednesday

The medical diagnostics company is having a strong day despite a so-so market.

| More on:
A group of three scientists talking excitedly while working in a lab on a diabetes test developed by Proteomics International Laboratories which is an ASX share tipped to explode by Alto Capital

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Sonic Healthcare Limited (ASX: SHL) share price is having a strong session this hump day.

At the time of writing, shares in the medical diagnostics company are trading for $40.73, up 3.77%. For context, the S&P/ASX 200 Index (ASX: XJO) is practically even on yesterday's close.

The company hasn't released any price sensitive news recently. So, what's going on?

Let's take a closer look.

Could learning to 'live with COVID' be the reason?

Since the first case of the delta variant of COVID in late June, thousands upon thousands of cases have been detected across the Australian mainland – shutting down New South Wales, Victoria, and the ACT for extended time periods.

But those days are over.

NSW and Victoria are out of lockdown and the ACT is practically there. Quarantine for international travel will also soon be a thing of the past. Australia has become a highly vaccinated country and is learning to live alongside the insidious virus.

Part of living with the virus means testing — and Sonic is the largest private testing provider in the country. It's raked in millions of dollars from government as people get tested by the tens of thousands. The Sonic share price had a massive rise during this latest outbreak. It's jumped 10.9% since the original case was detected in the Sydney limo driver.

Testing, contact tracing, and isolating positive COVID patients will still be a part of the Australian response to the disease.

As well, the Commonwealth government has today revealed the end of Australia's closed border policy. Come 1 November, Australians will no longer need a reason to leave the country. The date coincides with the day NSW and Victoria end all quarantine requirements for vaccinated travellers.

However, to fly overseas, passengers will need to conduct a PCR (polymerase chain reaction) test within 72 hours before departure. These tests can only be done in a clinical setting, meaning Sonic's revenue stream is not drying up anytime soon.

Investors may be jumping on this news, thus, potentially leading to a rising Sonic share price.

Sonic share price snapshot

Over the past 12 months, the Sonic share price has risen 13.5%. Since the start of 2021, shares in the medical company have risen 26.5%. Its 52-week high is $43.99 and its 52-week low is $30.21.

Sonic Healthcare has a market capitalisation of approximately $19.5 billion.

Motley Fool contributor Marc Sidarous has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

This bombshell for ASX healthcare shares could hit 6 million Australians

This could have a large impact.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

2 ASX healthcare shares having a stellar run today

The ASX healthcare sector is down today but these two stocks are bucking the trend.

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Why this $13 billion ASX 200 healthcare stock is surging today

A change in sentiment for the healthcare player.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX 200 stock hit a 52-week low and a top broker thinks it can rebound

Patient investors may see this stock make a pleasing recovery.

Read more »

A couple smile as they look at a pregnancy test.
Healthcare Shares

Why this sold-off ASX healthcare share could be an exciting dividend buy

This could be a healthy stock for dividends.

Read more »

a smiling woman sits at her computer at home with a coffee alongside her, as if pleased with her investments.
Healthcare Shares

Is CSL the best ASX 100 share to buy now?

Bell Potter has good things to say about this blue chip star.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Down 10% in a month, are CSL shares feeling the sting of a potential disruption?

Brokers are still bullish.

Read more »

One girl leapfrogs over her friend's back.
Healthcare Shares

Doubled in a year! Does this booming ASX share have another 24% upside?

Let's take a look.

Read more »